Transverse Myelitis

Preliminary Diagnosis: Transverse myelitis

I. What imaging technique is first-line for this diagnosis

  • MR imaging with IV contrast

II. Describe the advantages and disadvantages of this technique for diagnosis of transverse myelitis.


  • Diagnostic with positive pertinent findings: central cord lesion >2 vertebral body segments +/- patchy enhancement.

  • Able to locate the level of infection and inflammation and predict any neurological (sensory, motor) and specifically dermatomal abnormalities.

  • Able to rule out any secondary complications from a primary infectious or inflammatory transverse myelitis: such as discitis, osteomyelitis, or epidural abscess.

  • Does not use ionizing radiation.


  • Expensive

  • Time-consuming imaging modality

  • Requires significant patient cooperation to limit motion artifact.

  • 40-50% of cases of transverse myelitis are not demonstrated by MR.

III. What are the contraindications for the first-line imaging technique?

  • Contraindicated in patients with non-MR compatible hardware and noncompatible foreign bodies.

  • MR imaging with intravenous contrast requires that the patient have good renal function with GFR greater than 60. Administration of intravenous contrast is decided individually on a case-by-case basis with GFR < 60 and >30.

IV. What alternative imaging techniques are available?

  • No alternative diagnostic imaging modalities are available.

V. Describe the advantages and disadvantages of the alternative techniques for diagnosis of transverse myelitis.

  • Not Applicable

VI. What are the contraindications for the alternative imaging techniques?

  • Not Applicable

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs